Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03697850
Title Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy (BladderSpar)
Acronym BladderSpar
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.